[Corrigendum] PRIMA‑1 inhibits growth of breast cancer cells by re‑activating mutant p53 protein.

Subsequently to the publication of the above article, an interested reader drew to the authors' attention that, regarding the immunohistochemical images shown in Fig. 1B on p. 1018, the 'PAb1620/PM 25μM' and 'PAb1620/PM 50μM' data panels shown in Fig. 1B for the T47‑D and HCC‑1428 cell lines were apparently the same, sugggesting that this figure had been assembled incorrectly. After re‑examining their original data, the authors have realized that the 'PAb1620/PM 25μM' and 'PAb1620/PM 50μM' data panels correctly shown for the T47‑D cell line had inadvertently been copied across for the HCC‑1428 cell line. The revised version of Fig. 1, now showing all the correct data for the HCC‑1428 cell line in Fig. 1B, is shown below. The authors are grateful to the Editor of for allowing them this opportunity to publish a Corrigendum, and all the authors agree to its publication. Note that this error did not grossly affect either the results or the conclusions reported in this study; furthermore, the authors apologize to the readership for any inconvenience caused. [International Journal of Oncology 35: 1015‑1023, 2009; DOI: 10.3892/ijo_00000416].